Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type-Reference-Cited by-同舟云学术

Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type

Published:2021-10-11 Issue: Volume: Page:1-9
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Papagianni Aikaterini¹²,Ihne Sandra²³,Zeller Daniel¹²,Morbach Caroline²⁴,Üçeyler Nurcan¹,Sommer Claudia¹²

Affiliation:

1. Department of Neurology, University Hospital Würzburg, Würzburg, Germany

2. Interdisciplinary Amyloidosis Center of Northern Bavaria, University Hospital Würzburg, Würzburg, Germany

3. Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany

4. Comprehensive Heart Failure Centre (CHFC), University Hospital Würzburg, Würzburg, Germany

Funder

Pfizer

Pfizer Inc under Global Medical

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13506129.2021.1976751

Reference42 articles.

1. Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System

2. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy

3. Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan

4. First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy

5. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker;Clinical Autonomic Research;2024-05-20

2. Neurological affection and serum neurofilament light chain in wild type transthyretin amyloidosis;Scientific Reports;2024-05-02

3. Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker;2024-03-07

4. Neuromuscular manifestations of wild type transthyretin amyloidosis: a review and single center’s experience;Frontiers in Cardiovascular Medicine;2024-02-12

5. Update on Amyloid Polyneuropathy and Treatment;Current Treatment Options in Neurology;2024-02-01